The industry-first clearance allows the suite to detect, notify and triage the diagnosis of PTX. Chicago-based GE HealthCare’s updated algorithm expands the suite’s on-device triage capabilities, according to a news release. It provides immediate notification of the presence or absence of PTX, plus an overlay display both on-device and in PACS.
GE HealthCare said its latest update displays an overlay in the area where the suite locates a PTX when detected. It assists with PTX localization and improves the speed and accuracy of PTX diagnosis. By hosting the Critical Care Suite on-device, GE HealthCare makes critical insights available at the point of care across the care team.
The algorithm partially localizes 100% of all detected large PTXs and 96% of all detected small PTXs, the company said. It also limits false alerts with 94% specificity. Clinical studies also showed a 57% reduction in reporting times for clinical actionable PTXs and a 17.7% increase in clinical detection of small PTXs.
“Artificial intelligence applications in healthcare continue to prove their value in clinical practice and on the frontlines of patient care,” said Jyoti Gupta, president & CEO of Women’s Health and X-ray for GE HealthCare. “The adoption of these digital solutions helps unlock efficiencies across the entire clinical workflow and empowers radiologists and their teams in making critical decisions with confidence in time-sensitive situations. We are excited by the paradigm shift this kind of innovation can bring in the delivery of timely and efficient patient care enabling enhanced clinical outcomes when it matters most.”